Intranasal Therapy for Epistaxis in Patients With Hereditary Hemorrhagic...
This randomized clinical trial assesses whether topical therapy with either bevacizumab, estriol, or tranexamic acid that have differing mechanisms of action is effective in reducing hereditary...
View ArticleBevacizumab Nasal Spray for Epistaxis in Patients With HHT
This randomized trial investigates the efficacy of 3 different doses of bevacizumab nasal spray for reducing epistaxis duration in patients with hereditary hemorrhagic telangiectasia (HHT).
View Article
More Pages to Explore .....
